Mackenzie Financial »

Enanta Pharmaceuticals shares owned by Mackenzie Financial

Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Mackenzie Financial from 13F filings

Historical chart of Mackenzie Financial investment in Enanta Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Enanta Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enanta Pharmaceuticals by Mackenzie Financial

Quarter filed Position value Share count Share price at filing
2026-06-30 $982k 67k 14.58
2019-06-30 $3.2M 38k 84.39
2019-03-31 $278k 2.9k 95.53
2018-12-31 $212k 3.0k 70.67
2018-09-30 $2.5M 29k 85.47
2018-06-30 $4.1M 35k 115.90
2018-03-31 $1.5M 18k 80.91

More positions owned by Mackenzie Financial

Royal Bank of Canada Common Stock (RY)
Toronto-Dominion Bank/The Common Stock (TD)
State Street Corp Etp (SPY)
NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Bank of Montreal Common Stock (BMO)
Alphabet Common Stock (GOOGL)
Canadian Pacific Kansas City L Common Stock (CP)
Microsoft Corp Common Stock (MSFT)
Agnico Eagle Mines Common Stock (AEM)
Canadian Imperial Bank of Comm Common Stock (CM)
Manulife Financial Corp Common Stock (MFC)
Enbridge Common Stock (ENB)
Canadian Natural Resources Common Stock (CNQ)
Amazon.com Common Stock (AMZN)

View all positions for Mackenzie Financial

Top funds holding Enanta Pharmaceuticals

Henderson Group
Jupiter Topco
BlackRock
Krensavage Asset Management
Farallon Capital Management
Deep Track Capital
ADAR1 Capital Management
Vanguard Capital Management
Spruce Street Capital
Acadian Asset Management
Vanguard Portfolio Management
Geode Capital Management
Millennium Management
State Street Corporation
Renaissance Technologies

View all funds holding Enanta Pharmaceuticals